Gene · 6670
Papers4,287
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,287
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| EphrinA5 regulates cell motility by modulating Snhg15/DNA triplex-dependent targeting of DNMT1 to the Ncam1 promoter. | Epigenetics Chromatin | 2023 | 37880732 | PubTator, text mining | PubMed |
| Can we predict discordant RECIST 1.1 evaluations in double read clinical trials? | Front Oncol | 2023 | 37869080 | PubTator, text mining | PubMed |
| Advances in proteomics: characterization of the innate immune system after birth and during inflammation. | Front Immunol | 2023 | 37868984 | PubTator, text mining | PubMed |
| Experimental study on the thermal performance of ultra-thin flat heat pipes with novel multiscale striped composite wick structures. | Heliyon | 2023 | 37867792 | PubTator, text mining | PubMed |
| Unified Quantification of Quantum Defects in Small-Diameter Single-Walled Carbon Nanotubes by Raman Spectroscopy. | ACS Nano | 2023 | 37856164 | PubTator, text mining | PubMed |
| Potential Implications of Hyperoside on Oxidative Stress-Induced Human Diseases: A Comprehensive Review. | J Inflamm Res | 2023 | 37854313 | PubTator, text mining | PubMed |
| Exploring the role of natural bioactive molecules in genitourinary cancers: how far has research progressed? | Nat Prod Bioprospect | 2023 | 37843642 | PubTator, text mining | PubMed |
A Novel Strategy for the Synthesis of High Stability of Luminescent Zero Dimensional-Two Dimensional CsPbBr3 Quantum Dot/1,4-bis(4-methylstyryl)benzene Nanoplate Heterostructures at an Atmospheric Condition. | Nanomaterials (Basel) | 2023 | 37836364 | PubTator, text mining | PubMed |
| Epigenetic Modulators as Therapeutic Agents in Cancer. | Int J Mol Sci | 2023 | 37834411 | PubTator, text mining | PubMed |
| Proteomics Reveals mRNA Regulation and the Action of Annexins in Thyroid Cancer. | Int J Mol Sci | 2023 | 37833989 | PubTator, text mining | PubMed |
| Valorization Strategies in CO2 Capture: A New Life for Exhausted Silica-Polyethylenimine. | Int J Mol Sci | 2023 | 37833862 | PubTator, text mining | PubMed |
| The RNA methyltransferase METTL16 enhances cholangiocarcinoma growth through PRDM15-mediated FGFR4 expression. | J Exp Clin Cancer Res | 2023 | 37817227 | PubTator, text mining | PubMed |
| Structure-based design of a phosphotyrosine-masked covalent ligand targeting the E3 ligase SOCS2. | Nat Commun | 2023 | 37816714 | PubTator, text mining | PubMed |
| Lichens as bio-monitors of polycyclic aromatic hydrocarbons: Measuring the impact of features and traffic patterns. | Heliyon | 2023 | 37810017 | PubTator, text mining | PubMed |
| SARS-CoV-2 spike protein-derived immunogenic peptides that are promiscuously presented by several HLA-class II molecules and their potential for inducing acquired immunity. | Heliyon | 2023 | 37809871 | PubTator, text mining | PubMed |
| Mendelian randomization analyses explore the relationship between cathepsins and lung cancer. | Commun Biol | 2023 | 37805623 | PubTator, text mining | PubMed |
| The Golgi stacking protein GRASP55 is targeted by the natural compound prodigiosin. | Cell Commun Signal | 2023 | 37798768 | PubTator, text mining | PubMed |
| SHMT as a Potential Therapeutic Target for Renal Cell Carcinoma. | Front Biosci (Landmark Ed) | 2023 | 37796681 | PubTator, text mining | PubMed |
| ELK4 Promotes Colorectal Cancer Progression by Activating the Neoangiogenic Factor LRG1 in a Noncanonical SP1/3-Dependent Manner. | Adv Sci (Weinh) | 2023 | 37786278 | PubTator, text mining | PubMed |
| Propionate reinforces epithelial identity and reduces aggressiveness of lung carcinoma. | EMBO Mol Med | 2023 | 37766669 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6670/papers?page=12